Insider Transactions Reported by 17 Insiders of bioAffinity Technologies, Inc.

Symbol
BIAF, BIAFW on Nasdaq
Location
San Antonio, TX

There are no Buy or Sell transactions made by insiders since 24 Dec 2024

bioAffinity Technologies, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gary D. Rubin Director, 10%+ Owner $4.59M 01 Jul 2024
STEVEN GIRGENTI Executive Chairman, Director $2.85M 10 Jan 2025
Roby Joyce Director $1.72M 01 Jul 2024
Nathan Perlmutter 10%+ Owner $1.38M 06 Sep 2022
Maria Zannes President & CEO, Director $645K 10 Jan 2025
Mohsin Y. Meghji Director $454K 01 Oct 2023
Robert A. Anderson Director $434K 01 Jul 2024
PETER S. KNIGHT Director $311K 01 Jul 2024
James Michael Edwards VP and CFO $302K 10 Jan 2025
STUART DIAMOND Director $263K 01 Jul 2024
Jamie Platt Director $145K 01 Jul 2024
Michael Dougherty Chief Financial Officer $125K 31 Jan 2024
Timothy P. Zannes Secretary, EVP, Gen. Counsel $119K 10 Jan 2025
Vivienne Rebel Chief Sci. & Med. Officer, EVP $68.4K 31 Jan 2024
Xavier T. Reveles Chief Operating Officer $30.1K 10 Jan 2025
Roberto Rios Director $208 12 Aug 2025
John J. Oppenheimer Director 12 Aug 2025

Recent Insider Transactions by Companies or Individuals for bioAffinity Technologies, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.